DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Jilma-Stohlawetz P, Gilbert JC, Gorczyca ME, Knöbl P, Jilma B.
A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura.
Thromb Haemost 2011;
106 (03) 539-547
Access:
We do not assume any responsibility for the contents of the web pages of other providers.